GRF.MC - Grifols, S.A.

MCE - MCE Precio demorado. Divisa en EUR

Grifols, S.A.

Avinguda de la Generalitat
152-158Parc de Negocis Can Sant Joan
Barcelona 08174
Spain
34 93 571 05 00
http://www.grifols.com

SectorHealthcare
SectorBiotechnology
Empleados a tiempo completo16.808

Ejecutivos clave

NombreTítuloPagaEjecutadoEdad
Mr. Raimon Grifols RouraCo-Chief Exec. Officer and Exec. DirectorN/AN/A53
Mr. Ramón Riera RocaExec. VP, Pres of Global Commercial Division and Exec. Director913kN/A62
Mr. Tomás Dagá GelabertVice Sec. and External DirectorN/AN/A61
Mr. Víctor Grifols DeuCo-Chief Exec. Officer and Exec. DirectorN/AN/A40
Mr. Alfredo Arroyo GuerraChief Financial Officer and Corp. VPN/AN/A59
Los importes son a partir de 31 de diciembre de 2015 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company specializes in providing infusion solutions, nutrition products, and medical devices for use in hospitals and clinics. It operates through four segments: Bioscience, Diagnostic, Hospital, and Raw Materials and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use, including the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. This segment offers plasma products, such as IVIG, Factor VIII, A1PI, and albumin; and intramuscular immunoglobulins, ATIII, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products comprising analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. This segment serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment manufactures and installs products used by hospitals consisting of parenteral solutions, and enteral and parenteral nutritional fluids. The Raw Materials and Others segment sells intermediate biological products; and renders manufacturing services to third party companies. The company also offers engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Gobierno corporativo

El ISS Governance QualityScore de Grifols, S.A., a día 15 de octubre de 2017, es 3. Las puntuaciones base son Auditoría: 1; Tablero: 2; Derechos de los accionistas: 6; Compensación: 6.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.
Al usar Yahoo aceptas que Yahoo y sus socios puedan utilizar cookies para personalización y otros fines